Frequently Asked Questions | Monoclonal Antibody Therapy (mAbs) & Evusheld COVID Treatments

Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful viruses like SARS-CoV-2. Monoclonal antibodies attack the virus and reduce its ability to spread through your body.

No. Vaccination remains the most powerful tool against contracting COVID-19, as well as against hospitalization and death from COVID. mAbs is a therapy that helps those who have been exposed to or tested positive for COVID-19.

Yes. Those who are exposed or test positive for COVID-19 despite vaccination can qualify to receive monoclonal antibody treatment.

Yes, though it is recommended you wait 90 days post-treatment to get vaccinated.

No. Antibodies do not contain any live virus.

mAbs are authorized by the FDA for emergency use. Any medical infusion or injection may cause side effects, such as minor pain, bleeding, bruising, soreness, swelling, fever, chills, exhaustion, nausea, headache, and possible infection at the infusion site. In rare cases, hypersensitivity and allergic reactions may also occur during or after an antibody infusion. For this reason, trained healthcare staff will monitor patients during and after treatment.

Early treatment with mAbs may prevent the disease from worsening and lessen the length of COVID-19 symptoms. Additionally, it could prevent COVID-19 from spreading to your entire population or household.

Yes. The same treatment is used for both, and only the application process is different.

Once you qualify, we’ll reach out to you to schedule treatment. Treatment will be administered by a trained professional in the comfort of your own home. You can also search for a treatment site by going to the U.S. Department of Health and Human Services website, or by calling them at 1-877-332-6585 (for English) or 1-877-366-0310 (for Spanish).

Evusheld is a medicine administered to adults and adolescents over 12 years of age. Evusheld is for people who are immuno-compromised or cannot take the COVID-19 vaccine.

Evusheld offers a short term protection against COVID-19 and you may need additional doses for ongoing protection, depending on the variants of the COVID-19 that will develop.

Evusheld offers a short term protection against COVID-19 and you may need additional doses for ongoing protection, depending oYou’ll receive a home treatment visit. Evusheld is two injections, one following the other, and administration takes about three minutes. There is a one hour observation period following treatment.